Daily Peptide

The Daily Peptide Decoded Series. Vol. 2 BPC-157. The most talked about peptide in the recovery space. The most overstated and misunderstood. We did the digging. Here’s what the research actually says, what it doesn’t, and where it sits today. Which one’s next? Sema or Tirz?

@10BottleValueCo @peptidepirate Don’t let the pirate stuff fool you. This guy is impressive. He has some interesting anecdotal data that I think a lot of people enjoy relating to.

@peptidepirate For a pirate, you're surprisingly smart🥸

The ultimate recovery stack🩹📚🩹📚🩹 ——————————————————— Recovery cocktail 🍸 BPC-157🩹 GHK-cu🔵 Tb-500🛠️ These three heal through three completely different mechanisms which is exactly why they belong together🏴‍☠️ BPC-157 builds the roads🏴‍☠️ It drives angiogenesis new blood vessels into the damaged tissue and blood supply is what real healing runs on🏴‍☠️ TB-500 moves the workforce🏴‍☠️ It drives cell migration mobilizing your repair cells and pulling them toward the injury from across the body🏴‍☠️ GHK-Cu runs quality control🏴‍☠️ It carries copper the exact cofactor your body needs to cross link collagen properly🏴‍☠️ Without that copper your new collagen forms but stays weak and disorganized🏴‍☠️ GHK makes sure the tissue you rebuild is actually strong and well structured not just patched together🏴‍☠️ Why the three together beat any one alone🏴‍☠️ BPC lays the blood supply TB-500 brings the repair crew GHK makes sure they build it right🏴‍☠️ Three different bottlenecks in the repair process handled at the same time🏴‍☠️ But here is what almost nobody runs alongside it🏴‍☠️ The peptides send the repair signal but connective tissue is collagen and you cannot build collagen without the raw materials present🏴‍☠️ The support stack that moves the needle🏴‍☠️ Collagen or gelatin 15g because it delivers the glycine and proline that build the tendon and ligament matrix🏴‍☠️ Take it 30 to 60 minutes before you train or rehab the area because that is when the building blocks reach the repair site🏴‍☠️ Vitamin C with it because collagen cannot form without it as a cofactor and the combo produced a twofold jump in collagen synthesis in studies🏴‍☠️ Zinc because it is required for collagen synthesis and even mild deficiency slows healing🏴‍☠️ Omega-3 EPA and DHA to keep inflammation in the productive range not the range that blocks repair🏴‍☠️ Protein at 1 gram per pound as the base because the whole repair runs on amino acids🏴‍☠️ The supplement side has real human evidence which is exactly why dialing it in matters so much🏴‍☠️ The peptides start the repair the raw materials decide how far it gets🏴‍☠️ There is a reason these peptides are commonly found in a blend 🏴‍☠️ 🧬🔬

@the_stoic_cult True. Discipline is the foundation. But today’s environments are designed to make discipline harder than it’s ever been. The reward pathways these drugs target are the same ones being targeted by every grocery store layout, gambling app, and notification ping.

@DailyPeptide True temperance is attained when the mind governs the desires of the flesh through reason rather than relying solely on external tools to subdue the passions.

Studies are showing that GLP-1s can have effects on your dopamine receptors. It makes sense too. Your GLP-1 receptors are located in the same part of the brain as the dopamine signaling pathways. GLP-1s appear to activate receptors in the brain’s reward center, which dampens the dopamine response to rewards. There are people saying they’ve lost tons of weight on Reta. But the bigger story to me is the ones who lost the weight and lost the habits that put them in that place. Anecdotal of course, but these stories of quit drinking, no more gambling, less falling into temptation are real. It’s not as appealing as it used to sound. I’m not saying GLP-1s are miracle drugs that heal you from obesity, addiction, and straighten out your life. But I do believe GLP-1s have a lot more to offer than just weight loss. The data just needs to catch up. The real questions worth asking are: Are these effects durable after stopping a GLP-1? Is the dampening helpful for some but harmful for others? Do different GLP-1s have different effects on the reward system? What will the long-term implications look like for motivation, pleasure, and behavior change? This is the next chapter of the GLP-1 story. It’s bigger than weight loss.

@LevelVinny This is a win.

@DailyPeptide As a true addict. I cold turkey stopped drinking. It’s been like 4-5 times in 2 months. I’m also a little more “cold” as if I was on lexapro again, but not in a shut off way but more of a “I’m focused”

If there was a peptide that could tackle mental health the same way Reta is going after obesity, it would be one of the biggest drugs ever made. There are some discussions around GLP-1s affecting dopamine signaling and reward pathways. This is what leads to less cravings, some researchers are exploring if this extends to addiction patterns. Out of curiosity, has anyone experienced improvements in their mental health while on peptides? Could be placebo. Could be real. Either way the mental side doesn’t get talked about as much as the physical.

@wilhitr63 This is amazing. These compounds are changing peoples lives.

@DailyPeptide I work with my hands daily and every morning the osteoarthritis wakes me with hurting kuckels. The first day using GHK-CU & MOTS-C my hands not swollen and hurting. Life changing for me personally.

If you’ve used or plan on using one of these peptides you might want to pay attention. BPC-157, TB-500, MOTS-c, KPV, DSIP, Semax, Epitalon. These are the 7 peptides up for review in a little over a month from now. They aren’t getting FDA approved. That’s not what this PCAC review is. But you could see them being sold by your favorite telehealth company. The PCAC review isn’t about FDA drug approval. That’s what Reta is going through right now. This review is to see if these peptides can move from the current Category 2 (restricted from compounding) to Category 1 (allowed for compounding under 503A pharmacies). PCAC recommendations are advisory and are looked at as suggestions to the FDA. After the July 23-24 vote, the FDA still has to review the recommendation, then go through formal rulemaking before any peptide is officially moved off Category 2. That process can take months. But historically, the FDA follows PCAC recommendations. If even some of these peptides move to Category 1, your 503A pharmacy could legally compound them under a physician’s prescription. Telehealth platforms with 503A partnerships could dispense them at scale. This will be a defining moment for all peptides moving forward. Will these compounds be brought to the Telehealth path or will they be grey market forever?

@Temarinette @Scott57743499 Stories like this need to be told so others can relate.

@DailyPeptide @Scott57743499 I was on tirzepatide for 2 years and no effect on mental health. Started Reta almost 2 months ago and this has changed my life. All symptoms of my TDAH has vanished, better memory, better focus, sharpness, etc etc. Hasn't lost a single gram but i don't even care, i love Reta.

Zepbound is the brand name that Eli Lilly gave to Tirzepatide. Tirzepatide is a GLP-1 and it has GIP as well. The only thing that makes Reta is it has glucagon. In theory it should have the same effect across the board for GLP-1s. It’s more of the dopamine signals being quieted.

@DailyPeptide In the comments Reta was mentioned. Does this happen with Zepbound as well?

This is the angle that should be getting more research attention. The dopamine signaling extends beyond food, it sounds like. Some may try to weaponize this as a bad thing, people losing interest in things they used to enjoy. But I think it’s an advantage if you target the distractions.

@DailyPeptide Honestly the mental side has been crazy on Reta. I expected less food noise. I didn’t expect less interest in drinking, gambling, and all the other dumb ways I used to distract myself. Something definitely shifted.

@sonofearle The only way to know is tracking the data.

@DailyPeptide I actually think Reta has a chance to directly improve some mental health conditions.

@VGadev I’ll assume this is a win.

@DailyPeptide Reta put the kabbash on binge drinking

Bloomberg reports the black market is valued at $1-3 billion. The Bloomberg article notes that it’s only recording the value of API imports at WHOLESALE cost. The grey market vendors are taking on risk so there’s obviously a markup. Which means the grey market is multiples larger than this report. Imagine what this will look like when telehealth fully arrives.

@texas_trill12 The data can’t prove this, but no one can tell you that you’re wrong either.

@DailyPeptide My mental health is definitely better . Maybe it’s bc I’ve seen the weight drop so I’m more motivated but the other “addictions” i don’t even think about anymore either .

@NDMFlyHigh No gatekeeping. Just the possibility of these compounds being brought into a much bigger arena than the grey market is today.

@DailyPeptide Telehealth sure but grey will be here. Who wants a gatekeeper.

@ironveicleo @Aurelius_Health Tirzepatide is tried and true. There is a real debate over micro dosing or full doses going on right now. I believe that everyone’s body is different and it should be customized to your needs. Not a cookie cutter protocol.

@DailyPeptide i've tried a few things on this list, but tirzepatide is still the one i keep coming back to @Aurelius_Health got me paying attention to dose quality, not dose quantity, microdosing has been enough to get the benefits without feeling like my appetite got hit by a truck

The 20 peptides I see talked about most in the space right now. Semaglutide Tirzepatide Retatrutide Tesamorelin Sermorelin CJC-1295 Ipamorelin BPC-157 TB-500 GHK-Cu Thymosin Alpha-1 KPV LL-37 Semax Selank Dihexa MOTS-c Epitalon SS-31 Melanotan II If you don’t see your favorite on here, tell me what I’m missing?

@DrJesseMorse @stackapp Same here.

My goal is to be one of the pioneers of peptide education. It begins with the @stackapp Peptide Certification Course which will be available in the next 3 weeks. Not only English but available in over 30 languages!!! What happens after that is 🚀

I should clarify my take on this. GLP-1s are mainstream. Most people have heard of them. Different conversation. For peptides like BPC-157, TB-500, and the others up for PCAC review, the structural reality is different. Compounding pharmacies don’t operate on direct-to-consumer marketing budgets. They aren’t going to run Super Bowl ads or fund podcast to make these compounds household names. That’s not how their business model works. So even if the PCAC review opens the door for 7 peptides to be legally compounded through 503A pharmacies, the public education layer won’t follow the same path as a branded GLP-1. Creatine became mainstream through the supplement industry. Peptides won’t, because they’re prescription compounds going through pharmacies, not retail bottles on a GNC shelf.

@DailyPeptide So how come creatine is so well studied? Nobody could patent that either and yet….

There’s a class of peptides that will probably never see mainstream, but should. BPC-157. MOTS-c. TB-500. KPV. Epitalon. Selank. Semax. They all have one thing in common outside of the real mechanisms they offer. No commercial path to fund the trials that would prove them out. These peptides are natural sequences or short fragments. They can’t be patented as composition. Pharma won’t spend billions on a trial they can’t recoup. Academic researchers can’t fund it. So what happens? Foreign markets and the grey market keep them accessible. So they live in limbo. Real animal data. Growing anecdotal use. Still no path to the human evidence that would settle the conversation. That’s not the peptides’ fault. It’s the structural reality of how pharmaceutical research gets funded. For users, the takeaway is that the evidence gap on these compounds isn’t temporary. It’s permanent under the current system. The story will get told by anecdote, not by trial data. The only way this changes is if the current system changes.

@tarmakademia That’s right. A lot of people misunderstand it and think these compounds are getting FDA approved. It’s either going to stay in category 2 or move to category 1. If it moves to category 1 it will be legal for 503A compounding pharmacies to make them.

@DailyPeptide god i hate replying to ai turgid slop but here we are. most of those are up for review at the end of july to be put on the bulks list. good chance you'll be able to get them locally compounded if that's any interest.

@Johanna_KRJ I was wondering if someone would say this one.

@DailyPeptide I like DSIP, too